17 employees
Nectar builds a comprehensive, vertically integrated allergy healthcare platform leveraging data and clinical research.
2021
$17M
from 5 investors over 5 rounds
Nectar Allergy raised $17M on December 20, 2022
Investors: Harmony Partners, Obvious Ventures and Juxtapose
Nectar Allergy raised $8M on March 16, 2022
Investors: Obvious Ventures and Juxtapose